BRM421 Ophthalmic Solution in Patients With Limbal Stem Cell Deficiency

NCT07422389 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Limbal Stem Cell Deficiency (LSCD)

Interventions

DRUG: BRM421 Ophthalmic Solution, 0.06%

Sponsor

BRIM Biotechnology Inc.

Collaborators

[object Object]